Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
|
|
CASI Pharmaceuticals, Inc (DE) (CASI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/21/2022 |
SC 13D/A
| He Wei-Wu reports a 19% stake in CASI Pharmaceuticals, Inc. |
| 11/23/2021 |
SC 13D/A
| He Wei-Wu reports a 17.5% stake in CASI Pharmaceuticals, Inc. |
| 04/30/2021 |
SC 13D/A
| SPECTRUM PHARMACEUTICALS INC reports a 4.9% stake in CASI Pharmaceuticals, Inc. |
| 02/03/2021 |
SC 13D/A
| He Wei-Wu reports a 16.3% stake in CASI Pharmaceuticals, Inc. |
| 08/18/2020 |
SC 13D/A
| SPECTRUM PHARMACEUTICALS INC reports a 7.5% stake in CASI Pharmaceuticals, Inc. |
| 07/29/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/24/2020 |
SC 13D/A
| He Wei-Wu reports a 12.1% stake in CASI Pharmaceuticals, Inc. |
| 04/11/2019 |
SC 13D/A
| SPECTRUM PHARMACEUTICALS INC reports a 10.5% stake in CASI Pharmaceuticals, Inc. |
| 11/14/2018 |
SC 13D/A
| SPARKLE BYTE LTD reports a 11.8% stake in CASI Pharmaceuticals, Inc. |
| 05/14/2018 |
SC 13D/A
| SPECTRUM PHARMACEUTICALS INC reports a 13.4% stake in CASI Pharmaceuticals, Inc. |
| 04/04/2018 |
SC 13D/A
| He Wei-Wu reports a 10.4% stake in CASI Pharmaceuticals, Inc. |
| 03/20/2018 |
SC 13D/A
| Ho Chi Sing reports a 15.1% stake in CASI PHARMACEUTICALS, INC. |
| 12/05/2016 |
SC 13D/A
| SPARKLE BYTE LTD reports a 16.5% stake in CASI Pharmaceuticals, Inc. |
| 03/06/2013 |
SC 13D/A
| Ho Chi Sing reports a 30.4% stake in ENTREMED, INC. |
| 06/11/2012 |
SC 13D/A
| Ho Chi Sing reports a 23.5% stake in ENTREMED, INC. |
| 02/02/2012 |
SC 13D/A
| ENTREMED INC reports a 42.6% stake in ENTREMED, INC. |
| 03/13/2006 |
SC 13D/A
| CELGENE CORP has filed a Schedule 13D for ENTREMED, INC. |
| 04/04/2005 |
SC 13D/A
| CELGENE CORP has filed a Schedule 13D for ENTREMED, INC. |
| 04/13/1999 |
SC 13D/A
| MILLS VALUE ADVISER INC /ADV reports a 5.2% stake in ENTREMED, INC. |
| 04/13/1999 |
SC 13D/A
| MARTIN JAMES T reports a 4% stake in ENTREMED, INC. |
| 02/26/1999 |
SC 13D/A
| MARTIN JAMES T reports a 5.1% stake in ENTREMED, INC. |
| 02/26/1999 |
SC 13D/A
| MILLS VALUE ADVISER INC /ADV reports a 6.3% stake in ENTREMED, INC. |
| 02/04/1999 |
SC 13D/A
| MARTIN JAMES T reports a 6% stake in ENTREMED, INC. |
| 02/04/1999 |
SC 13D/A
| MARTIN JAMES T reports a 7.3% stake in ENTREMED, INC. |
| 01/29/1999 |
SC 13D/A
| MILLS VALUE ADVISER INC /ADV reports a 6.1% stake in ENTREMED, INC. |
|
|